Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pediatrix Medical (MD) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to 14.61%.

  • Pediatrix Medical's EBITDA Margin rose 104700.0% to 14.61% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.47%, marking a year-over-year increase of 209500.0%. This contributed to the annual value of 4.86% for FY2024, which is 19100.0% down from last year.
  • Per Pediatrix Medical's latest filing, its EBITDA Margin stood at 14.61% for Q3 2025, which was up 104700.0% from 8.47% recorded in Q2 2025.
  • In the past 5 years, Pediatrix Medical's EBITDA Margin registered a high of 14.61% during Q3 2025, and its lowest value of 30.3% during Q2 2024.
  • In the last 5 years, Pediatrix Medical's EBITDA Margin had a median value of 5.57% in 2023 and averaged 2.66%.
  • As far as peak fluctuations go, Pediatrix Medical's EBITDA Margin crashed by -358800bps in 2024, and later skyrocketed by 387700bps in 2025.
  • Quarter analysis of 5 years shows Pediatrix Medical's EBITDA Margin stood at 13.64% in 2021, then crashed by -57bps to 5.84% in 2022, then crashed by -524bps to 24.77% in 2023, then surged by 124bps to 5.9% in 2024, then surged by 148bps to 14.61% in 2025.
  • Its EBITDA Margin stands at 14.61% for Q3 2025, versus 8.47% for Q2 2025 and 4.69% for Q1 2025.